TMEM16A/ANO1 calcium-activated chloride channel as a novel target for the treatment of human respiratory syncytial virus infection.

Hayley PearsonEleanor J A A ToddMareike AhrendsSamantha E HoverAdrian WhitehouseMartin StaceyJonathan D LippiatLudwig WilkensHans-Gerd FieguthOlga DanovChristina HesseJohn N BarrJamel Mankouri

Published in: Thorax (2020)

These findings reveal TMEM16A as an exciting target for future host-directed antiviral therapeutics.

Keyphrases

respiratory syncytial virus
endothelial cells
current status
induced pluripotent stem cells
single cell
combination therapy